FLUDARA

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

FLUDARABINE PHOSPHATE 50 MG/VIAL

Pieejams no:

SANOFI - AVENTIS ISRAEL LTD

ATĶ kods:

L01BB05

Zāļu forma:

POWDER FOR SOLUTION FOR INJ/INF

Ievadīšanas:

I.V

Ražojis:

GENZYME EUROPE B.V., NETHERLANDS

Ārstniecības grupa:

FLUDARABINE

Ārstēšanas norādes:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

Autorizācija datums:

2009-02-01